IMMUTEP Ltd Files Form 6-K

Ticker: PRRUF · Form: 6-K · Filed: Oct 3, 2024 · CIK: 1506184

Immutep Ltd 6-K Filing Summary
FieldDetail
CompanyImmutep Ltd (PRRUF)
Form Type6-K
Filed DateOct 3, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, foreign-private-issuer, company-update

TL;DR

IMMUTEP Ltd (IMMU) filed a 6-K on Oct 3rd. Standard update for foreign issuers.

AI Summary

On October 3, 2024, IMMUTEP Ltd filed a Form 6-K. The company, previously known as Prima BioMed Ltd, is incorporated in Australia and operates in the pharmaceutical preparations sector. Its principal executive office is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.

Why It Matters

This filing indicates IMMUTEP Ltd is providing updated information to the SEC, which is standard for foreign private issuers and may contain material updates for investors.

Risk Assessment

Risk Level: low — A Form 6-K is a routine filing for foreign private issuers and typically does not contain significant new financial or operational information.

Key Players & Entities

  • IMMUTEP Ltd (company) — Registrant
  • Prima BioMed Ltd (company) — Former company name
  • October 3, 2024 (date) — Filing date
  • 264 George Street, Sydney NSW 2000, Australia (location) — Principal executive office address

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.

When was IMMUTEP Ltd previously known by another name?

IMMUTEP Ltd was formerly known as Prima BioMed Ltd, with a date of name change on November 19, 2010.

What is IMMUTEP Ltd's primary business sector?

IMMUTEP Ltd is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.

Where is IMMUTEP Ltd's principal executive office located?

The principal executive office of IMMUTEP Ltd is located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.

Does IMMUTEP Ltd file annual reports under Form 20-F?

Yes, IMMUTEP Ltd indicates it files or will file annual reports under cover of Form 20-F.

Filing Stats: 261 words · 1 min read · ~1 pages · Grade level 17.2 · Accepted 2024-10-03 06:06:56

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: October 3, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.